Myosin Therapeutics is a Jupiter, FL-based biotechnology company spun out of The Herbert Wertheim UF Scripps Institute (formerly Scripps Research, Florida). The company is focused on developing therapies for neuroscience and oncology indications using a platform that targets molecular nanomotor proteins.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 03/03/25 | $3,000,000 | Seed 2 |
DeepWork Capital Dynagrow Capital Florida Opportunity Fund Mayo Clinic Ventures Mint12 Pharma Sontag Family Trust | undisclosed |
